Fifth Third Bancorp Biogen Inc. Transaction History

Fifth Third Bancorp

$26.1 Billion
Q2 2024

A detailed history of Fifth Third Bancorp transactions in Biogen Inc. stock. As of the latest transaction made, Fifth Third Bancorp holds 3,536 shares of BIIB stock, worth $691,747. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,536

Previous 2,985 18.46%

Holding current value

$691,747

Previous $643,000 27.37%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 22, 2024	BUY	$190.52 - $236.72 $104,976 - $130,432	551 Added 18.46%	3,536 $819,000
Q1 2024 Apr 23, 2024	SELL	$212.02 - $267.71 $28,622 - $36,140	-135 Reduced 4.33%	2,985 $643,000
Q4 2023 Jan 19, 2024	SELL	$222.59 - $267.94 $29,159 - $35,100	-131 Reduced 4.03%	3,120 $807,000
Q3 2023 Oct 31, 2023	SELL	$253.3 - $285.89 $178,323 - $201,266	-704 Reduced 17.8%	3,251 $835,000
Q2 2023 Jul 25, 2023	BUY	$275.25 - $318.06 $13,212 - $15,266	48 Added 1.23%	3,955 $1.13 Million
Q1 2023 Apr 24, 2023	BUY	$256.56 - $292.34 $139,055 - $158,448	542 Added 16.11%	3,907 $1.09 Million
Q4 2022 Jan 25, 2023	BUY	$252.44 - $306.72 $96,936 - $117,780	384 Added 12.88%	3,365 $0
Q3 2022 Oct 25, 2022	SELL	$194.69 - $268.46 $14,991 - $20,671	-77 Reduced 2.52%	2,981 $796,000
Q2 2022 Aug 04, 2022	SELL	$187.54 - $223.02 $42,008 - $49,956	-224 Reduced 6.83%	3,058 $624,000
Q1 2022 Apr 19, 2022	SELL	$193.77 - $244.14 $1.16 Million - $1.47 Million	-6,002 Reduced 64.65%	3,282 $691,000
Q4 2021 Feb 01, 2022	SELL	$223.92 - $287.77 $412,684 - $530,360	-1,843 Reduced 16.56%	9,284 $2.23 Million
Q3 2021 Oct 15, 2021	SELL	$282.99 - $369.05 $1.76 Million - $2.3 Million	-6,220 Reduced 35.86%	11,127 $3.15 Million
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $1.09 Million - $1.75 Million	-4,217 Reduced 19.56%	17,347 $6.01 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $522,585 - $612,239	-2,151 Reduced 9.07%	21,564 $6.03 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $615,693 - $926,771	-2,606 Reduced 9.9%	23,715 $5.81 Million
Q3 2020 Nov 09, 2020	SELL	$264.77 - $305.71 $590,437 - $681,733	-2,230 Reduced 7.81%	26,321 $7.47 Million
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $292,544 - $387,424	-1,131 Reduced 3.81%	28,551 $7.64 Million
Q1 2020 May 05, 2020	SELL	$268.85 - $341.04 $1.58 Million - $2.01 Million	-5,885 Reduced 16.55%	29,682 $9.39 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $2.1 Million - $2.9 Million	-9,544 Reduced 21.16%	35,567 $10.6 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $3.38 Million - $3.79 Million	-15,539 Reduced 25.62%	45,111 $10.5 Million
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $581,995 - $641,524	-2,654 Reduced 4.19%	60,650 $14.2 Million
Q1 2019 May 14, 2019	SELL	$216.71 - $338.96 $2.05 Million - $3.21 Million	-9,469 Reduced 13.01%	63,304 $15 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $4.18 Million - $5.29 Million	-15,005 Reduced 17.09%	72,773 $21.9 Million
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $2.79 Million - $3.65 Million	9,522 Added 12.17%	87,778 $31 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $35,537 - $42,353	138 Added 0.18%	78,256 $22.7 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $1.26 Million - $1.78 Million	4,828 Added 6.59%	78,118 $21.4 Million
Q4 2017 Feb 14, 2018	SELL	$307.64 - $344.58 $728,491 - $815,965	-2,368 Reduced 3.13%	73,290 $23.3 Million
Q3 2017 Nov 14, 2017	SELL	$281.15 - $329.69 $244,881 - $287,159	-871 Reduced 1.14%	75,658 $23.7 Million
Q2 2017 Aug 11, 2017	BUY	N/A	76,529	76,529 $20.8 Million

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $28.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fifth Third Bancorp, based on Form 13F filings with the SEC.

News

Stay updated on Fifth Third Bancorp with notifications on news.

Account

Fifth Third Bancorp Biogen Inc. Transaction History